English Version English Version
  MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
cepii_hygiene.png
 
 
 
Hauptnavigation
  • Home
  • Allgemeine Informationen
  • Gesundheitsbereich
  • Lehre
  • Forschung
  • News Daten
 
HAI /
 
Subnavigation

Events

 

Tumour immunology and cancer immunotherapy

For the doctoral thesis Seminar # 902.218weiter

 

Immunity to SARS-CoV-2: Exploring and understanding the COVID-19 disease

For the doctoral thesis Seminar # 902.218weiter

 

11th EFIS-EJI South Eastern European Immunology School (SEEIS2019)

September 27 - 30, 2019 in Pristina, Kosovoweiter

 

20th International Symposium on Health-Related Water Microbiology (International Water Association - IWA)


September 15 – 20, 2019, Vienna, Austriaweiter

 

International Symposium on Tick-Borne Pathogens and Disease ITPD 2019

September 8 – 11, 2019, Austria Trend Parkhotel Schönbrunn, Vienna, Austria – under the auspices of the Austrian Society for Hygiene, Microbiology and Preventive Medicine (ÖGHMP).weiter

 

Hygiene-Symposium zum 90. Geburtstag von Heinz Flamm

3. Juli 2019, 11 Uhr, Hygiene-Institut, Kinderspitalgasse 15, Hörsaal 1weiter

 

8th International Conference on Swimming Pool and Spa (ICSPS)

March 18 – 22, 2019, Marseille, France weiter

 

2019 World Congress of the International Ultraviolet Association (IUVA)


February 10 – 13, 2019, Sydney, Australia weiter

 

Symposium „Ground Water Resource Systems Vienna“ (GWRS Vienna)

Neue Wege der Analyse und Management der mikrobiologischen Qualität von Trinkwasser aus Grundwasserressourcen, 7. November 2018, 9 – 17 Uhr, TU Wien, Getreidemarkt 9weiter

 

10th EFIS-EJI South Eastern European Immunology School (SEEIS2018)

19 – 22 October 2018 in Yerevan, Armeniaweiter

 

2nd Viennese T-Cell Colloquium

Friday, October 5, 2018, 11:00 – 17:30, Jugendstilhörsaal, Medical University of Viennaweiter

 

13th EFIS-EJI Tatra Immunology Conference

June 9 – 13, 2018 in Strbske Pleso, Slovakiaweiter

 

36. Jahrestagung der Österreichischen Gesellschaft für Hygiene, Mikrobiologie und Präventivmedizin (ÖGHMP)

4. – 7. Juni 2018, Messe Congress, Grazweiter

 

2nd Disinfection and Disinfection By-Products Conference (IWA Specialist Group)

May 14 – 18, 2018 Beijing, China weiter

 

EACTS - PACT Joint Symposium "Regenerative Medicine: Taking the Science to the Patient"

November 30 – December 1, 2017, Vienna, Austria weiter

 

International Symposium on Tick-Borne Pathogens and Disease ITPD 2017

September 24 – 26, 2017, Austria Trend Parkhotel Schönbrunn, Vienna, Austria – under the auspices of the Austrian Society for Hygiene, Microbiology and Preventive Medicine (ÖGHMP). Organisers ÖGHMP and ESGBOR/ESCMID Study Group...weiter

 

2017 World Congress IUVA (International Ultraviolet Association)

17. – 20. September 2017, Dubrovnik, Kroatienweiter

 

9. EFIS-EJI South Eastern European Immunology School (SEEIS2017)

8 – 11 September 2017 in Lviv, Ukraineweiter

 

How Dead is Dead Conference V

6. – 8. September 2017, Universitätszahnklinik Wienweiter

 

8. EFIS-EJI South Eastern European Immunology School (SEEIS2016)

14 – 17 October 2016 in Durres, Albaniaweiter

 
Treffer 1 bis 20 von 52
<< Erste < Vorherige 1 2 3 Nächste > Letzte >>
 
Inhaltsbereich

Tumour immunology and cancer immunotherapy

For the doctoral thesis Seminar # 902.218

Program (pdf)

For the doctoral thesis Seminar # 902.218

Coordination:

Prof. Dr. Anna Repic, Prof. Dr. Johannes Huppa, Dr. Philipp Schatzlmaier,
Dr. René Platzer, Prof. Dr. Hannes Stockinger

Topic for the Winter semester 2021/2022:

 

Tumour immunology and cancer immunotherapy

 

Venue:

 

Virtual meeting via Webex
Time: January 31st - February 1st, 2022

Day 1: Monday January 31st:

Meeting: Link
Meeting number (access code): 2734 900 6241,
Meeting password: d7nKGVP5kh7 (37654875 from video systems)

11.00 – 11.15 Coordinators (+ Vladimir Leksa)

Welcome, Introduction to and Overview of the Topic

11.15 – 11.35 Philipp Brunmayr

Hallmarks of cancer, general aspects of cellular transformation, types of cancer (introductory lecture)

11.35 – 11.50 Discussion

11.50 – 12.10 Lena Wagner

Immunosurveillance, immunoediting and tumour evasion mechanisms (plus effects of the tumor on local and systemic immune regulation

12.10 – 12.25 Discussion

12.25 – 12.50 Lunch Break

12.50 – 13.10 Vanessa Mühlgrabner

TILs: what they are, do and recognize

13.10 – 13.25 Discussion

13.25 – 13.45 Angelika Plach

Role of tumor-associated lymphocytes (Treg, Breg) and IgG4 antibodies in cancer progression

13.45 – 14.00 Discussion

14.00 – 14.20 Philipp Schatzlmaier

Inflammaging, chronic infections and cancer

14.20 – 14.35 Discussion

14.35 – 14.55 Gabor Tajti

In the hood - Tumor microenvironment as a way to hide from the immune system (supportive stromal cells, extracellular matrix, tumor vasculature, genetic profile of immune cells within the tumor mass, etc.)

14.55 – 15.10 Discussion

15.10 – 15.30 Malgorzata Kupc

Usability, differences and immunological relevance of various cancer models (cell lines vs. spheroids/organoids vs. ex vivo tumour explants vs. (orthotopic) xenografts in mice spontaneous tumours in mice)

15.30 – 15.45 Discussion

 

Day 2: Tuesday February 1st:

Meeting: Link
Meeting number (access code): 2734 763 3118,
Meeting password: VVh3cpJ7Hy4 (88432757 from video systems)

 

 

11.00 – 11.20 Anna Repic (+ introduction to day 2)

Role of innate immunity in cancer, tumour-associated myeloid cells with immunosuppressive functions (MDSC, TAM, TAN)

11.20 – 11.35 Discussion

11.35 – 11.55 Romana PRaženicová

Cancer vaccination (peptide- or RNA-based) and ex vivo and in vivo strategies for dendritic cell-based immunotherapy

11.55 – 12.10 Discussion

12.10 – 12.30 René Platzer

Antibody-based therapy in cancer: Immune checkpoint inhibitors, BiTEs, immunoconjugates, ADCC etc.

12.30 – 12.45 Discussion

12.45 – 13.10 Break

13.10 – 13.20 Venu Gudipati

Chimeric (antibody-based) antigen receptor (CAR) immunotherapy (differences in different CAR generations, CAR T cell therapy in the clinic (+indications), and in development

13.20 – 13.35 Discussion

13.35 – 13.55 Lucas Teuschl

One size fits all cell therapy? MR1-T cells, NK cells, gamma-delta T cells, etc.

13.55 – 14.10 Discussion

14.10 – 14.20 Laura Gebetsberger

Oncolytic virus therapy

14.20 – 14.35 Discussion

14.35 – 14.55 Milena Weber

Future trends in cancer immune therapy (TCR-engineering, combination therapies, nanomedicine-based therapies, mRNA vaccines, etc.)

14.55 – 15.10 Discussion

15.10 – 15.40 Final discussion


Additionally, the following talk will be given at one of the next lab meetings (in February 2022)

Timo Peters

Tumor antigens and immunogenicity: fundamental differences between TCR- and antibody/CAR-mediated recognition, on the role of allelic HLA-variability and other genetic predispositions to recognizing tumor antigens

zurück zu: HAI
 
 
Drucken
 

Schnellinfo

 
-- Institutsleitung / Sekretariat
-- Befundauskunft + Probenannahme
-- News Archiv
-- Events
-- Intranet Login
-- Jobbörse
 
 

Featured

 
 
 
 
 
 
 
© MedUni Wien  | 
 Impressum | Nutzungsbedingungen | Datenschutzerklärung | Barrierefreiheit |Kontakt